Series B startup

Who invested in OncoDNA

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2020, from 1 source

Latest round
Series B, $21MFeb 2020
Investors
1
See who backed them

The rounds

  1. Feb 2020
    Series B$21M

    Source recorded

Founders and team

From OncoDNA's own website: 11 on the team.

  • Adriana TerradezChief Commercial Officer
  • François DegraveChief Information Officer
  • Jean-Pol DetiffeChief Strategy & Innovation Officer
  • Koenraad EyckenChief Product Officer
  • Virginie DecosterChief Financial Officer
  • Manuelle PuissantHead Of HR
  • An HerremansDirector
  • Charles-André BrouwersExecutive Chairman
  • François BlondelDirector
  • François FontaineDirector
  • Guy GeldhofDirector

Everyone who backed them

Verve VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about OncoDNA

Who invested in OncoDNA?

OncoDNA's investors include Verve Ventures.

How much has OncoDNA raised?

OncoDNA has raised $21M across 1 round since 2020.

When did OncoDNA last raise?

OncoDNA's most recent round was a Series B of $21M in Feb 2020.

What was OncoDNA's biggest round?

Its most recent round, $21M in Feb 2020, is also its largest on record.

Who backed OncoDNA first?

OncoDNA's first round on record, in Feb 2020, was backed by Verve Ventures.

What stage is OncoDNA at?

OncoDNA's latest named round is a Series B, in Feb 2020.

Companies like OncoDNA

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.